Abstract:Objective To investigate the predictive values of matrix metalloproteinase-9 (MMP-9) and serum ferritin (SF) for hemorrhagic transformation (HT) after acute ischemic stroke.Methods The patients with fist-ever acute ischemic stroke within 24 h of onset were selected.The demographic and clinical data were collected.The MMP-9 and SF levels were detected.The demographic and clinical data and laboratory results were compared between a HT group and a non-HT group.Multivariable logistic regression analysis was used to determine the independent risk factor for HT.The receiver operating characteristic (ROC) curve was used to identify the predictive values of MMP-9 and SF for HT.Results A total of 150 patients were enrolled,their mean age was 67.01 ± 9.11 years,including 65 males (43.33％).There were 32 patients (21.33％) in the HT group and 118 (78.67％) in the non-HT group.Univariate analysis showed that MMP-9 (161.19 ±36.86 μg/L vs.100.18 ±36.70 μg/L;t =8.333,P＜0.001) and SF (195.50 [188.25-201.00] μg/L vs.175.00[165.00-189.25] μg/L;Z =4.891,P ＜0.001) in the HT group were significantly higher than those in the non-HT group.Multivariable logistic regression analysis showed that diabetes (odds ratio [OR] 2.273,95％ confidence interval [CI] 1.019-5.070;P =0.047),atrial fibrillation (OR 4.846,95％ CI 1.934-12.146;P=0.001),MMP-9 (OR 3.176,95％ CI 1.842-5.479;P＜ 0.001),hypersensitivity C reactive protein (OR 2.243,95％ CI 1.015-4.954;P =0.045),and SF (OR 2.722,95％ CI 1.586-4.672;P ＜ 0.001) were the independent risk factors for HT.The ROC curve analysis showed that MMP-9 (area under curve 0.904,95％ CI 0.851-0.957) and SF (area under curve 0.776,95％ CI 0.684-0.869) had significant predictive values for HT.When the cut-off value of MMP-9 was 133 μg/L,the sensitivity and specificity were 84.4％ and 15.3％,respectively.When the cut-off value of SF was 187.5 μg/L,the sensitivity and specificity were 78.1％ and 27.1％,respectively.Conclusions The MMP-9 and SF levels were significantly increased in acute ischemic stroke patients with HT.Early detection of serum MMP-9 and SF levels help to predict the risk of HT.

The Change and Clinic Significance of MMP-9 and TIMP-1 in Acute Ischemic Stroke

Relationship Between Matrix Metalloproteinase-9 and Tissue Metalloproteinase Inhibitor-1 and Carotid Atheromatous Plaque Stability

Dynamic Changes and Prognostic Value of Gut Microbiota-Dependent Trimethylamine-N-Oxide in Acute Ischemic Stroke.

The clinic relevance between acute coronary syndrome and the level of serum matrix metalloproteinase-9

The Marker of Unstable Carotid Atheromatous Plaque in Cerebral Infarction Patients

Value of Matrix Metalloproteinase - 9 and Ischemia - Modified Albumin for Diagnosis of Coronary Heart Disease

The Changes of Serum Matrix Metalloproteinase-9 and Tissue Inhibitor Metalloproteinase-1 in Essential Hypertension

Clinical significance of serum interleukin-18 (IL-18) and matrix metalloproteinase-(MMP-9) on acute coronary syndrome

Relationship between Serum Inflammatory Biomarkers and Ischemic Cerebrovascular Diseases

Study on the Changes of Serum Levels of Interleukin-1β(IL-1β) and C-Reactive Protein(CRP) in Patients with Acute Cerebral Infarction

Expression and Significance of Matrix Matalloproteinase and Tissue Inhibitor of Metalloproteinase in Human Astrocytomas

Analysis of the expression of nine secreted matrix metalloproteinases and their endogenous inhibitors in the brain of mice subjected to ischaemic stroke

Changes and Implication of Peripheral Blood Levels of Matrix Metalloproteases-9 and C-reactive Protein in Patients with Coronary Artery Disease

Exploring the Role of MMP-9 and MMP-9/TIMP-1 Ratio in Subacute Stroke Recovery: A Prospective Observational Study

Significance of plasma matrix metalloproteinase-9 in hemorrhagic transformation of patients with acute cerebral infarction

Predictive values of serum matrix metalloproteinase-9 and ferritin for hemorrhagic transformation after acute ischemic stroke

Matrix Metalloproteinase Expression Is Related to Hemorrhagic Transformation After Cardioembolic Stroke

The predictive value of plasma stromal cell derived factor 1 on the pregnosis of acute ischemic stroke

The Relationship Between T2 White-Matter Hyperintensities and Hemorrhagic Transformation and Neurological Outcome after Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke

Abstract TP155: Predictive Value of Plasma Matrix Metalloproteinase-9 Concentrations for Hemorrhagic Transformation in Acute Ischemic Stroke: A Systematic Review and Diagnostic Accuracy Meta-Analysis

Differences in Acute Expression of Matrix Metalloproteinases-9, 3, and 2 Related to the Duration of Brain Ischemia and Tissue Plasminogen Activator Treatment in Experimental Stroke